Other metabolic risk abnormalities included in the new MAFLD diagnosis were also considered in the present study, including plasma triglycerides, HDL, prediabetes, fasting glucose, HbA1c, and CRP (Table 3). The gene discussed is CRP; the disease is prediabetes syndrome.